BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30859559)

  • 1. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome.
    Pagnamenta AT; Kaisaki PJ; Bennett F; Burkitt-Wright E; Martin HC; Ferla MP; Taylor JM; Gompertz L; Lahiri N; Tatton-Brown K; Newbury-Ecob R; Henderson A; Joss S; Weber A; Carmichael J; Turnpenny PD; McKee S; Forzano F; Ashraf T; Bradbury K; Shears D; Kini U; de Burca A; ; Blair E; Taylor JC; Stewart H
    Clin Genet; 2019 Jun; 95(6):693-703. PubMed ID: 30859559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.
    Umeki I; Niihori T; Abe T; Kanno SI; Okamoto N; Mizuno S; Kurosawa K; Nagasaki K; Yoshida M; Ohashi H; Inoue SI; Matsubara Y; Fujiwara I; Kure S; Aoki Y
    Hum Genet; 2019 Jan; 138(1):21-35. PubMed ID: 30368668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants.
    Johnston JJ; van der Smagt JJ; Rosenfeld JA; Pagnamenta AT; Alswaid A; Baker EH; Blair E; Borck G; Brinkmann J; Craigen W; Dung VC; Emrick L; Everman DB; van Gassen KL; Gulsuner S; Harr MH; Jain M; Kuechler A; Leppig KA; McDonald-McGinn DM; Can NTB; Peleg A; Roeder ER; Rogers RC; Sagi-Dain L; Sapp JC; Schäffer AA; Schanze D; Stewart H; Taylor JC; Verbeek NE; Walkiewicz MA; Zackai EH; Zweier C; ; Zenker M; Lee B; Biesecker LG
    Genet Med; 2018 Oct; 20(10):1175-1185. PubMed ID: 29469822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LZTR1: Genotype Expansion in Noonan Syndrome.
    Güemes M; Martín-Rivada Á; Ortiz-Cabrera NV; Martos-Moreno GÁ; Pozo-Román J; Argente J
    Horm Res Paediatr; 2019; 92(4):269-275. PubMed ID: 31533111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
    Yamamoto GL; Aguena M; Gos M; Hung C; Pilch J; Fahiminiya S; Abramowicz A; Cristian I; Buscarilli M; Naslavsky MS; Malaquias AC; Zatz M; Bodamer O; Majewski J; Jorge AA; Pereira AC; Kim CA; Passos-Bueno MR; Bertola DR
    J Med Genet; 2015 Jun; 52(6):413-21. PubMed ID: 25795793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Providing more evidence on LZTR1 variants in Noonan syndrome patients.
    Chinton J; Huckstadt V; Mucciolo M; Lepri F; Novelli A; Gravina LP; Obregon MG
    Am J Med Genet A; 2020 Feb; 182(2):409-414. PubMed ID: 31825158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Chinese family with Noonan syndrome caused by a heterozygous variant in LZTR1: a case report and literature review.
    Zhao X; Li Z; Wang L; Lan Z; Lin F; Zhang W; Su Z
    BMC Endocr Disord; 2021 Jan; 21(1):2. PubMed ID: 33407364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling.
    Motta M; Fidan M; Bellacchio E; Pantaleoni F; Schneider-Heieck K; Coppola S; Borck G; Salviati L; Zenker M; Cirstea IC; Tartaglia M
    Hum Mol Genet; 2019 Mar; 28(6):1007-1022. PubMed ID: 30481304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants presented with thick nuchal translucency and cardiac abnormalities.
    Yu QX; Zhen L; Lin XM; Wen YJ; Li DZ
    Prenat Diagn; 2023 Dec; 43(13):1662-1665. PubMed ID: 37936555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.
    Farncombe KM; Thain E; Barnett-Tapia C; Sadeghian H; Kim RH
    BMC Med Genomics; 2022 Jul; 15(1):160. PubMed ID: 35840934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal recessive Noonan-like syndrome caused by homozygosity for a previously unreported variant in SPRED2.
    Markholt S; Andreasen L; Bjerre J; Gregersen PA; Andersen BN
    Eur J Med Genet; 2023 Feb; 66(2):104695. PubMed ID: 36608738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1.
    Uludağ Alkaya D; Lissewski C; Yeşil G; Zenker M; Tüysüz B
    Am J Med Genet A; 2021 Dec; 185(12):3623-3633. PubMed ID: 34184824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digenic inheritance of subclinical variants in Noonan Syndrome patients: an alternative pathogenic model?
    Ferrari L; Mangano E; Bonati MT; Monterosso I; Capitanio D; Chiappori F; Brambilla I; Gelfi C; Battaglia C; Bordoni R; Riva P
    Eur J Hum Genet; 2020 Oct; 28(10):1432-1445. PubMed ID: 32514133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients.
    Li X; Yao R; Tan X; Li N; Ding Y; Li J; Chang G; Chen Y; Ma L; Wang J; Fu L; Wang X
    Clin Genet; 2019 Oct; 96(4):290-299. PubMed ID: 31219622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligo-astrocytoma in LZTR1-related Noonan syndrome.
    Jacquinet A; Bonnard A; Capri Y; Martin D; Sadzot B; Bianchi E; Servais L; Sacré JP; Cavé H; Verloes A
    Eur J Med Genet; 2020 Jan; 63(1):103617. PubMed ID: 30664951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders.
    Xu S; Fan Y; Sun Y; Wang L; Gu X; Yu Y
    BMC Med Genomics; 2017 Oct; 10(1):62. PubMed ID: 29084544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noonan syndrome-associated biallelic LZTR1 mutations cause cardiac hypertrophy and vascular malformations in zebrafish.
    Nakagama Y; Takeda N; Ogawa S; Takeda H; Furutani Y; Nakanishi T; Sato T; Hirata Y; Oka A; Inuzuka R
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1107. PubMed ID: 31883238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome.
    Vissers LE; Bonetti M; Paardekooper Overman J; Nillesen WM; Frints SG; de Ligt J; Zampino G; Justino A; Machado JC; Schepens M; Brunner HG; Veltman JA; Scheffer H; Gros P; Costa JL; Tartaglia M; van der Burgt I; Yntema HG; den Hertog J
    Eur J Hum Genet; 2015 Mar; 23(3):317-24. PubMed ID: 24939586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome-Associated Cardiomyopathy.
    Hanses U; Kleinsorge M; Roos L; Yigit G; Li Y; Barbarics B; El-Battrawy I; Lan H; Tiburcy M; Hindmarsh R; Lenz C; Salinas G; Diecke S; Müller C; Adham I; Altmüller J; Nürnberg P; Paul T; Zimmermann WH; Hasenfuss G; Wollnik B; Cyganek L
    Circulation; 2020 Sep; 142(11):1059-1076. PubMed ID: 32623905
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.